Robert Langer

Robert Langer: Edison of Medicine | Lex Fridman Podcast #105

Robert Langer, Lex Fridman, Bob Langer

MIT Professor Bob Langer, one of history's most cited researchers, has launched over 40 biotech companies and driven the field forward by pioneering controlled-release polymer systems for drug delivery and scaffold-based tissue engineering. His career highlights the rigorous 28-year journey from initial angiogenesis discovery to the 2004 FDA approval of Avastin, emphasizing that successful commercialization requires strategic business acumen alongside scientific innovation to navigate high clinical trial costs. Looking ahead, Langer predicts that curing cancer will depend on integrating deep biological insights with advanced engineering, while he maintains that his enduring legacy lies in mentoring nearly 1,000 students who now lead major research institutions and corporations.